Press Release – C2 Pharma

EDQM Grants C2 PHARMA CEP Approval for Commercial Sale of Cyclopentolate Hydrochloride

Posted on 27. June 202327. June 2023 by admin_c2p

C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API

Posted on 13. June 202327. June 2023 by admin_c2p

C² PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio

Posted on 9. November 202116. May 2023 by admin

C² PHARMA Completes Multiple Regulatory Filings, Expands Portfolio

Posted on 23. February 202116. May 2023 by admin

C² PHARMA Acquires Digoxin API Portfolio from Nobilus Ent

Posted on 20. March 201923. February 2021 by admin

Validation

Posted on 4. October 20183. October 2022 by admin

C2 PHARMA leads

Posted on 4. October 20183. October 2022 by admin

Acquisition

Posted on 22. June 20181. October 2018 by admin

Willkommen zur deutschen Version von WordPress. Dies ist der erste Beitrag. Du kannst ihn bearbeiten oder löschen. Und dann starte mit dem Schreiben!